Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
Mason, Barbara
Display my h-index
Publications in VIVO
 
    Export Publications Table
co-author
Co-author Network
map of science
Map of Science
Biosketch in .docx format  Create Biosketch

Mason, Barbara

Faculty Member
share the uri qr icon Close

Positions

  • 2017 - Professor, Neuroscience , Scripps Research
  • 2009 - Adjunct Professor, Department of Psychiatry, University of San Diego
  • 2003 - Adjunct Professor, Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami
  • 2003 - Director, Pearson Center for Alcohol and Addiction Research , Scripps Research
  • 2007 - 2017 Pearson Family Chair, Neuroscience , Scripps Research
  • 2006 - 2017 Professor, Committee on the Neurobiology of Addictive Disorders (CNAD) , Scripps Research
  • 2003 - 2006 Professor, Molecular and Integrative Neurosciences (MIND) , Scripps Research
  • 2000 - 2003 Professor with Tenure, Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Miami
  • 1993 - 2003 Director, Division of Substance Abuse, Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Miami
  • 1992 - 2003 Adjunct Faculty, The Rockefeller University
  • 1997 - 2000 Associate Professor with Tenure, Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Miami
  • 1991 - 1997 Associate Professor, Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Miami
  • 1990 - 1991 Chief, Alcohol Disorders Clinic, Department of Psychiatry, New York Hospital / Cornell Medical Center
  • 1987 - 1991 Assistant Professor of Psychology, Department of Psychiatry, Cornell University Medical College
  • 1984 - 1987 Instructor of Psychology, Department of Psychiatry, Cornell University Medical College
  • 1981 - 1984 Research Associate, Department of Psychiatry, Cornell University Medical College
  • 1981 - 1984 Assistant Professor of Psychology, Long Island University
  • 1980 - 1981 Psychology Intern, St. Luke's-Roosevelt Hospital Center
Dr. Barbara Mason explores the physiological changes in the brain that drive excessive drinking and create vulnerability to relapse, and she investigates the viability of utilizing new compounds to modulate the neurological effects of alcohol, reduce excessive intake, and prevent relapse.

Contact

  • mason@scripps.edu

Websites

  • Barbara Mason, Ph.D.
  • Laboratory Website
  • Pearson Center for Alcoholism and Addiction Research
  • Publications
  • Affiliation
  • Research
  • Background
  • Contact
  • View All
scroll to property group menus

Publications

recent publications
  • All Publications
  • PubMed Display for Export
  • Publications without PubMed PMIDs

  • academic article

    • Falk, D. E., Ryan, M. L., Fertig, J. B., Devine, E. G., Cruz, R., Brown, E. S., Burns, H., Salloum, I. M., Newport, D. J., Mendelson, J., Galloway, G., Kampman, K., et al. Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety Alcoholism-Clinical and Experimental Research  2019 43:158-169  DOI:10.1111/acer.13917  PMID:30403402  PMCID:PMC6317996
    • Mason, B. J., Quello, S., Shadan, F. Gabapentin for the treatment of alcohol use disorder Expert Opinion on Investigational Drugs  2018 27:113-124  DOI:10.1080/13543784.2018.1417383  PMID:29241365
    • Frantz, K., Roberto, M., Mason, B., Koob, G. F., Volkow, N., de Fonseca, F. R. Larry Parsons: Researcher, mentor, and friend Addiction Biology  2018 23:1204-1206  DOI:10.1111/adb.12686  PMID:30485629
    • Mason, B. J. Emerging pharmacotherapies for alcohol use disorder Neuropharmacology  2017 122:244-253  DOI:10.1016/j.neuropharm.2017.04.032  PMID:28454983
    • Koob, G. F., Mason, B. J. Existing and future drugs for the treatment of the dark side of addiction Annual Review of Pharmacology and Toxicology  2016 56:299-322  DOI:10.1146/annurev-pharmtox-010715-103143  PMID:26514207
    • Mason, B. J. Acamprosate, alcoholism, and abstinence Journal of Clinical Psychiatry  2015 76:E224-E225  DOI:10.4088/JCP.14com09632  PMID:25742214
    • Vendruscolo, L. F., Estey, D., Goodell, V., Macshane, L. G., Logrip, M. L., Schlosburg, J. E., McGinn, M. A., Zamora-Martinez, E. R., Belanoff, J. K., Hunt, H. J., Sanna, P. P., George, O., et al. Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals Journal of Clinical Investigation  2015 125:3193-3197  DOI:10.1172/jci79828  PMID:26121746
    • Perney, P., Rigole, H., Mason, B., Dematteis, M., Lehert, P. Measuring sleep disturbances in patients with alcohol use disorders: a short questionnaire suitable for routine practice Journal of Addiction Medicine  2015 9:25-30  DOI:10.1097/adm.0000000000000063  PMID:25629883
    • Araos, P., Pedraz, M., Serrano, A., Lucena, M., Barrios, V., Garcia-Marchena, N., Campos-Cloute, R., Ruiz, J. J., Romero, P., Suarez, J., Baixeras, E., de la Torre, R., et al. Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity Addiction Biology  2015 20:756-772  DOI:10.1111/adb.12156  PMID:24854157
    • Mason, B. J., Quello, S., Goodell, V., Shadan, F., Kyle, M., Begovic, A. Gabapentin treatment for alcohol dependence: a randomized clinical trial JAMA Internal Medicine  2014 174:70-77  DOI:10.1001/jamainternmed.2013.11950  PMID:24190578  PMCID:PMC3920987
    • Mason, B. J., Higley, A. E. A translational approach to novel medication development for protracted abstinence Current Topics in Behavioral Neurosciences  2013 13:647-70  DOI:10.1007/7854_2012_201  PMID:22351425
    • Mason, B. J., Crean, R., Goodell, V., Light, J. M., Quello, S., Shadan, F., Buffkins, K., Kyle, M., Adusumalli, M., Begovic, A., Rao, S. A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults Neuropsychopharmacology  2012 37:1689-1698  DOI:10.1038/npp.2012.14  PMID:22373942  PMCID:PMC3358737
    • Mason, B. J., Lehert, P. Acamprosate for alcohol dependence: A sex-specific meta-analysis based on individual patient data Alcoholism-Clinical and Experimental Research  2012 36:497-508  DOI:10.1111/j.1530-0277.2011.01616.x  PMID:21895717  PMCID:PMC3288465
    • Perney, P., Lehert, P., Mason, B. J. Sleep disturbance in alcoholism: Proposal of a simple measurement, and results from a 24-week randomized controlled study of alcohol-dependent patients assessing acamprosate efficacy Alcohol and Alcoholism  2012 47:133-139  DOI:10.1093/alcalc/agr160  PMID:22218671
    • Higley, A. E., Koob, G. F., Mason, B. J. Treatment of alcohol dependence with drug antagonists of the stress response Alcohol Research: Current Reviews  2012 34:516-521  PMID:23584117  PMCID:PMC3860394
    • Crean, R. D., Crane, N. A., Mason, B. J. An evidence-based review of acute and long-term effects of cannabis use on executive cognitive functions Journal of Addiction Medicine  2011 5:1-8  DOI:10.1097/ADM.0b013e31820c23fa  PMID:21321675  PMCID:PMC3037578
    • Higley, A. E., Crane, N. A., Spadoni, A. D., Quello, S. B., Goodell, V., Mason, B. J. Craving in response to stress induction in a human laboratory paradigm predicts treatment outcome in alcohol-dependent individuals Psychopharmacology  2011 218:121-129  DOI:10.1007/s00213-011-2355-8  PMID:21607563  PMCID:PMC3191263
    • Crean, R. D., Tapert, S. F., Minassian, A., MacDonald, K., Crane, N. A., Mason, B. J. Effects of chronic, heavy cannabis use on executive functions Journal of Addiction Medicine  2011 5:9-15  DOI:10.1097/ADM.0b013e31820cdd57  PMID:21643485  PMCID:PMC3106308
    • Mason, B. J., Heyser, C. J. Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence CNS & Neurological Disorders-Drug Targets  2010 9:23-32  DOI:10.2174/187152710790966641  PMID:20201812  PMCID:PMC2853976
    • Mason, B. J., Lehert, P. The effects of current subsyndromal psychiatric symptoms or past psychopathology on alcohol dependence treatment outcomes and acamprosate efficacy American Journal on Addictions  2010 19:147-154  DOI:10.1111/j.1521-0391.2009.00013.x  PMID:20163387
    • Mason, B. J., Heyser, C. J. The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence Expert Opinion on Drug Safety  2010 9:177-188  DOI:10.1517/14740330903512943  PMID:20021295
    • Koob, G. F., Lloyd, G. K., Mason, B. J. Development of pharmacotherapies for drug addiction: a Rosetta stone approach Nature Reviews Drug Discovery  2009 8:500-515  DOI:10.1038/nrd2828  PMID:19483710  PMCID:PMC2760328
    • Mason, B. J., Lehert, P. Effects of nicotine and illicit substance use on alcoholism treatment outcomes and acamprosate efficacy Journal of Addiction Medicine  2009 3:164-171  DOI:10.1097/ADM.0b013e3181917d53  PMID:21769013
    • Mason, B. J., Light, J. M., Williams, L. D., Drobes, D. J. Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: Effects of gabapentin Addiction Biology  2009 14:73-83  DOI:10.1111/j.1369-1600.2008.00133.x  PMID:18855801  PMCID:PMC2758315
    • Mason, B. J., Shaham, Y., Weiss, F., Le, A. D. Stress, alcohol craving, and relapse risk: mechanisms and viable treatment targets Alcohol  2009 43:541-543  DOI:10.1016/j.alcohol.2009.09.024  PMID:19913197  PMCID:PMC2805701
    • Mason, B. J., Light, J. M., Escher, T., Drobes, D. J. Effect of positive and negative affective stimuli and beverage cues on measures of craving in non treatment-seeking alcoholics Psychopharmacology  2008 200:141-150  DOI:10.1007/s00213-008-1192-x  PMID:18604601  PMCID:PMC2758314
    • Mason, B. J., Crean, R. Acamprosate in the treatment of alcohol dependence: clinical and economic considerations Expert Review of Neurotherapeutics  2007 7:1465-77  DOI:10.1586/14737175.7.11.1465  PMID:17997696
    • Mason, B. J. Acamprosate for alcohol dependence: an update for the clinician FOCUS: The Journal of Lifelong Learning in Psychiatry  2006 4:505-511
    • Anton, R. F., O'Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., Longabaugh, R., Mason, B. J., et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial JAMA-Journal of the American Medical Association  2006 295:2003-2017  DOI:10.1001/jama.295.17.2003  PMID:16670409
    • Mason, B. J., Goodman, A. M., Chabac, S., Lehert, P. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation Journal of Psychiatric Research  2006 40:383-393  DOI:10.1016/j.jpsychires.2006.02.002  PMID:16546214
    • Kranzler, H. R., Mueller, T., Cornelius, J., Pettinati, H. M., Moak, D., Martin, P. R., Anthenelli, R., Brower, K. J., O'Malley, S., Mason, B. J., Hasin, D., Keller, M. Sertraline treatment of co-occurring alcohol dependence and major depression Journal of Clinical Psychopharmacology  2006 26:13-20  DOI:10.1097/01.jcp.0000194620.61868.35  PMID:16415699
    • Johnson, B. A., Koob, G. F., Schuckit, M. A., Mason, B. J., Ait-Daoud, N. Understanding and treating alcohol dependence Alcoholism-Clinical and Experimental Research  2006 30:567-584  DOI:10.1111/j.1530-0277.2005.00066.x  PMID:16499499
    • Mason, B. J. Acamprosate in the treatment of alcohol dependence Expert Opinion on Pharmacotherapy  2005 6:2103-2115  DOI:10.1517/14656566.6.12.2103  PMID:16197362
    • O'Malley, S. S., Martin, D. J., Hosking, J. D., Mason, B. J. How pilot studies improve large-scale clinical trials: lessons learned from the COMBINE Study Journal of Studies on Alcohol  2005 15:66-71  PMID:16223058
    • Mason, B. J. Rationale for combining acamprosate and naltrexone for treating alcohol dependence Journal of Studies on Alcohol  2005 15:148-156  PMID:16223066
    • Mason, B. J. Acamprosate Recent Developments in Alcoholism  2003 16:203-215  PMID:12638639
    • Mason, B. J. Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment European Neuropsychopharmacology  2003 13:469-475  DOI:10.1016/j.euroneuro.2003.08.009  PMID:14636963
    • Anton, R., Randall, C., Latham, P., Ciraulo, D., LoCastro, J., Donovan, D., Kivlahan, D., Saxon, A., Johnson, B., Roache, J., Tiouririne, N. A. D., Mason, B., et al. Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE study): a pilot feasibility study Alcoholism-Clinical and Experimental Research  2003 27:1123-1131  DOI:10.1097/01.alc.0000078020.92938.0b  PMID:12878918
    • Anton, R., Randall, C., Latham, P., Ciraulo, D., LoCastro, J., Donovan, D., Kivlahan, D., Saxon, A., Johnson, B., Roache, J., Mason, B., Salvato, F., et al. Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods Alcoholism-Clinical and Experimental Research  2003 27:1107-1122  DOI:10.1097/01.alc.0000086765.46408.64  PMID:12878917
    • Mason, B. J., Goodman, A. M., Dixon, R. M., Hameed, M. H. A., Hulot, T., Wesnes, K., Hunter, J. A. A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone Neuropsychopharmacology  2002 27:596-606  DOI:10.1016/s0893-133x(02)00368-8  PMID:12377396
    • Koob, G. F., Mason, B. J., De Witte, P., Littleton, J., Siggins, G. R. Potential neuroprotective effects of acamprosate Alcoholism-Clinical and Experimental Research  2002 26:586-592  DOI:10.1111/j.1530-0277.2002.tb02578.x  PMID:11981137
    • Xie, S., Suckow, R. F., Mason, B. J., Allen, D., Cooper, T. B. Rapid and sensitive determination of nalmefene in human plasma by gas chromatography-mass spectrometry Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences  2002 773:143-149  DOI:10.1016/s1570-0232(02)00138-1  PMID:12031840
    • Boening, J. A. L., Lesch, O. M., Spanagel, R., Wolffgramm, J., Narita, M., Sinclair, D., Mason, B. J., Wiesbeck, G. A. Pharmacological relapse prevention in alcohol dependence: from animal models to clinical trials Alcoholism-Clinical and Experimental Research  2001 25:127S-131S  DOI:10.1097/00000374-200105051-00022  PMID:11391061
    • Mason, B. J. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review Journal of Clinical Psychiatry  2001 62:42-48  PMID:11584875
    • Mason, B. J., Ownby, R. L. Acamprosate for the treatment of alcohol dependence: a review of double-blind, placebo-controlled trials CNS Spectrums  2000 5:58-69  PMID:18296999
    • Mason, B. J., Salvato, F. R., Williams, L. D., Ritvo, E. C., Cutler, R. B. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence Archives of General Psychiatry  1999 56:719-724  DOI:10.1001/archpsyc.56.8.719  PMID:10435606
    • Mason, B. J., Kocsis, J. H., Melia, D., Khuri, E. T., Sweeney, J., Wells, A., Borg, L., Millman, R. B., Kreek, M. J. Psychiatric comorbidity in methadone maintained patients Journal of Addictive Diseases  1998 17:75-89  DOI:10.1300/J069v17n03_07  PMID:9789161
    • Mason, B. J., Kocsis, J. H., Ritvo, E. C., Cutler, R. B. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression JAMA-Journal of the American Medical Association  1996 275:761-767  DOI:10.1001/jama.275.10.761  PMID:8598592
    • Ownby, R. L., Mason, B. J., Eisdorfer, C. Alcohol abuse among older adults and the elderly Journal of Practical Psychiatry & Behavioral Health  1996 2:216-222
    • Mason, B. J. Dosing issues in the pharmacotherapy of alcoholism Alcoholism-Clinical and Experimental Research  1996 20:A10-A16  DOI:10.1111/j.1530-0277.1996.tb01184.x  PMID:8904989
    • Johnson, B. A., Jasinski, D. R., Galloway, G. P., Kranzler, H., Weinreib, R., Anton, R. F., Mason, B. J., Bohn, M. J., Pettinati, H. M., Rawson, R., Clyde, C. Ritanserin in the treatment of alcohol dependence: a multi-center clinical trial Psychopharmacology  1996 128:206-215  DOI:10.1007/s002130050126  PMID:8956382
    • Williams, L. D., Mason, B. J., Goldberg, G., Cutler, R. B. Women and minorities representation in alcoholism treatment research Psychopharmacology Bulletin  1996 32:201-204  PMID:8783889
    • Mason, B. J., Ritvo, E. C., Morgan, R. O., Salvato, F. R., Goldberg, G., Welch, B., Manteroatienza, E. A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence Alcoholism-Clinical and Experimental Research  1994 18:1162-1167  DOI:10.1111/j.1530-0277.1994.tb00098.x  PMID:7847600
    • Salvato, F. R., Mason, B. J. Changes in transaminases over the course of a 12-week, double-blind nalmefene trial in a 38-year-old female subject Alcoholism-Clinical and Experimental Research  1994 18:1187-1189  DOI:10.1111/j.1530-0277.1994.tb00102.x  PMID:7847604
    • Mason, B. J., Kocsis, J. H., Leon, A. C., Thompson, S., Frances, A. J., Morgan, R. O., Parides, M. K. Measurement of severity and treatment response in dysthymia Psychiatric Annals  1993 23:625-631
    • Mason, B. J. Depression in alcoholism: diagnosis and treatment Science Matters  1992 2:33-36
    • Mason, B. J., Kocsis, J. H. Desipramine treatment of alcoholism Psychopharmacology Bulletin  1991 27:155-161  PMID:1924663
    • Mason, B. J., Kocsis, J. H., Frances, A. J., Mann, J. J. Amoxapine versus amitriptyline for continuation therapy of depression Journal of Clinical Psychopharmacology  1990 10:338-343  PMID:2258450
    • Frances, A., Kocsis, J., Marin, D., Manning, D., Markowitz, J., Mason, B., Widiger, T. Diagnostic criteria for dysthymic disorder Psychopharmacology Bulletin  1989 25:325-329  PMID:2697006
    • Kocsis, J. H., Mason, B. J., Frances, A. J., Sweeney, J., Mann, J. J., Marin, D. Prediction of response of chronic depression to imipramine Journal of Affective Disorders  1989 17:255-260  DOI:10.1016/0165-0327(89)90008-6  PMID:2529294
    • Kocsis, J. H., Frances, A. J., Voss, C., Mason, B. J., Mann, J. J., Sweeney, J. Imipramine and social-vocational adjustment in chronic depression American Journal of Psychiatry  1988 145:997-999  PMID:3394886
    • Kocsis, J. H., Frances, A. J., Voss, C., Mann, J. J., Mason, B. J., Sweeney, J. Imipramine treatment for chronic depression Archives of General Psychiatry  1988 45:253-257  DOI:10.1001/archpsyc.1988.01800270071008  PMID:3277579
    • Mason, B. J., Kocsis, J. H. Methods and issues in psychopharmacological studies Drugs & Society  1988 2:83-91  DOI:10.1300/J023v02n02_06
    • Brown, R. P., Mason, B., Stoll, P., Brizer, D., Kocsis, J., Stokes, P. E., Mann, J. J. Adrenocortical function and suicidal behavior in depressive disorders Psychiatry Research  1986 17:317-323  DOI:10.1016/0165-1781(86)90079-x  PMID:3714913
    • Kocsis, J. H., Kennedy, S., Brown, R. P., Mann, J. J., Mason, B. Suicide and adrenocortical function Psychopharmacology Bulletin  1986 22:650-655  PMID:3797571
    • Exner Jr., J. E., Thomas, E. A., Mason, B. Children's Rorschachs: description and prediction Journal of Personality Assessment  1985 49:13-20  DOI:10.1207/s15327752jpa4901_3  PMID:3989648
    • Escobar, J. I., Mann, J. J., Keller, J., Wilkins, J., Mason, B., Mills, M. J. Comparison of injectable molindone and haloperidol followed by oral dosage forms in acutely ill schizophrenics Journal of Clinical Psychiatry  1985 46:15-19  PMID:3894337
    • Kocsis, J. H., Frances, A., Mann, J. J., Sweeney, J., Voss, C., Mason, B., Brown, R. P. Imipramine for treatment of chronic depression Psychopharmacology Bulletin  1985 21:698-700  PMID:3898184
    • Mason, B. J., Cohen, J. B., Exner, J. E., Jr. Schizophrenic, depressive, and nonpatient personality organizations described by Rorschach factor structures Journal of Personality Assessment  1985 49:295-305  DOI:10.1207/s15327752jpa4903_16  PMID:4032208

featured in

  • Clinical Trial Indicates Gabapentin Is Safe and Effective for Treating Alcohol Dependence  News Release
  • New Pearson Family Chair at Scripps Research to Support Forward-Looking Alcohol and Addiction Research: Barbara Mason Appointed First to Hold Endowed Position  Newsletter
  • Scripps Research Scientists Find Anticonvulsant Drug Helps Marijuana Smokers Kick The Habit  News Release
  • Scripps Research Team Wins $4 Million Grant to Study Effects of Chronic Marijuana Use  News Release
  • Study Results Offer Guidance in Treatment of Alcohol Dependence  News Release
scroll to property group menus

Affiliation

head of

  • Alcohol Research Center of Excellence (P60) Director 2017 -
  • Pearson Center for Alcohol and Addiction Research Director 2003 -
scroll to property group menus

Research

research overview

  • Medication Development for Protracted Abstinence in Alcohol Dependence and Related Substance Dependence Disorders

    The focus of the research programs in the Division of Clinical Psychopharmacology is the clinical evaluation of potential medications for protracted abstinence and relapse prevention in alcohol use disorder and related conditions such as nicotine and cannabis use disorder. Research projects range from proof-of-concept early phase human laboratory studies to long-term, double-blind, placebo-controlled clinical efficacy studies. A critical aspect of the conceptual framework under which the Division of Clinical Psychopharmacology is predicated is the dynamic feedback from the research findings of pre-clinical and clinical studies, which are designed to streamline information and provide converging evidence for ultimate clinical use. The critical conceptual framework is that the pre-clinical animal studies will inform the clinical laboratory studies, and the clinical laboratory studies will in turn inform the pre-clinical animal studies to further refine basic research involving animal models and the neuropharmacological approach. This approach has identified neuropharmacological domains that are currently being translated into long-term clinical efficacy studies.

scroll to property group menus

Background

education and training

  • Ph.D. in Clinical Psychology, Long Island University 1983
  • B.F.A., Pratt Institute 1972
scroll to property group menus

Contact

full name

  • Barbara J. Mason

geographic location

  • Scripps California 

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support